Medikationssteuerung bei PatientInnen mit Depression und Multimorbidität

Affiliation
Institut für Allgemeinmedizin, Klinikum der Ludwig-Maximilians-Universität München

Funktion
Professor für Klinische Versorgungsforschung (W2)

Arbeitsschwerpunkte

Pharmakoepidemiologie; Entwicklung und Evaluation von Interventionen zur Verbesserung der Pharmakotherapie in der ambulanten Versorgung

Stationen akademische Ausbildung

2013 MSc (with distinction) in Pharmacoepidemiology, EU2P consortium of 7 European Universities led by University of Bordeaux

2012 PhD in Clinical Pharmacy, University of Strathclyde, Glasgow, UK

2005 MSc (with distinction) in Clinical Pharmacy, University of Strathclyde, Glasgow, UK

2001 3.Staatsexamen Pharmazie, Universität Bonn

2000 2.Staatsexamen Pharmazie, Universität Bonn

Stationen berufliche Tätigkeiten

Seit 2019 W2 Professor für klinische Versorgungsforschung; Institut für Allgemeinmedizin, Klinikum der Ludwig-Maximilians-Universität München

2014-2019 Senior Lecturer, NHS Tayside/University of Dundee, UK

2009-2014 Research fellow, NHS Tayside/University of Dundee, UK

Mitgliedschaften
Funktionen

Deutsche Gesellschaft für Versorgungsforschung

European Society of Clinical Pharmacy

Deutsche Gesellschaft für Allgemein- und Familienmedizin

Deutsche Pharmazeutische Gesellschaft

Netzwerk Evidenzbasierte Medizin

Preise

2017 Royal College of General Practitioners: Paper of the year award (Category winner Health Services Research)

2016 Scottish Health Awards Innovation category finalist

2014 International Primary Care Research Leadership Programme, University of Dundee/University of Oxford

Wissenschaftliche Publikationen

• Mair A, Wilson M, Dreischulte T. Addressing the Challenge of Polypharmacy. Annual review of pharmacology and toxicology. 2020;60:661-81.
• Dreischulte T, Grant A, Hapca A, Guthrie B. Process evaluation of the Data-driven Quality Improvement in Primary Care (DQIP) trial: quantitative examination of variation between practices in recruitment, implementation and effectiveness. BMJ open. 2018;8(1):e017133.
• Grant A, Dreischulte T, Guthrie B. Process evaluation of the Data-driven Quality Improvement in Primary Care (DQIP) trial: case study evaluation of adoption and maintenance of a complex intervention to reduce high-risk primary care prescribing. BMJ open. 2017;7(3):e015281.
• Grant A, Dreischulte T, Guthrie B. Process evaluation of the data-driven quality improvement in primary care (DQIP) trial: active and less active ingredients of a multi-component complex intervention to reduce high-risk primary care prescribing. Implementation science : IS. 2017;12(1):4.
• Guthrie B, Yu N, Murphy D, Donnan PT, Dreischulte T. Health Services and Delivery Research. Measuring prevalence, reliability and variation in high-risk prescribing in general practice using multilevel modelling of observational data in a population database. Southampton (UK): NIHR Journals Library
• Guthrie B, Makubate B, Hernandez-Santiago V, Dreischulte T. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010. BMC medicine. 2015;13:74.
• Dreischulte T, Morales DR, Bell S, Guthrie B. Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury. Kidney international. 2015;88(2):396-403.
• Grant AM, Guthrie B, Dreischulte T. Developing a complex intervention to improve prescribing safety in primary care: mixed methods feasibility and optimisation pilot study. BMJ open. 2014;4(1):e004153.
• Grant A, Treweek S, Dreischulte T, Foy R, Guthrie B. Process evaluations for cluster-randomised trials of complex interventions: a proposed framework for design and reporting. Trials. 2013;14:15.
• Dreischulte T, Grant AM, McCowan C, McAnaw JJ, Guthrie B. Quality and safety of medication use in primary care: consensus validation of a new set of explicit medication assessment criteria and prioritisation of topics for improvement. BMC clinical pharmacology. 2012;12:5.
• Dreischulte T, Grant A, Donnan P, McCowan C, Davey P, Petrie D, et al. A cluster randomised stepped wedge trial to evaluate the effectiveness of a multifaceted information technology-based intervention in reducing high-risk prescribing of non-steroidal anti-inflammatory drugs and antiplatelets in primary medical care: the DQIP study protocol. Implementation science : IS. 2012;7:24.
• 12. Guthrie B, McCowan C, Davey P, Simpson CR, Dreischulte T, Barnett K. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. Bmj. 2011;342:d3514.

Affiliation
Institut für Allgemeinmedizin, LMU Klinikum

Affiliation
Institut für Allgemeinmedizin, LMU Klinikum

Stationen akademische Ausbildung

09.2014-09.2020 Studium der Humanmedizin, Medical University Varna (Bulgarien)
11.2020-09.2021 Doktorand und Mitarbeiter, Spezialambulanz für Tabakabhängigkeit, Klinikum der Universität München
10.2021-heute Weiterbildung zum Facharzt für Allgemeinmedizin, Graduiertenkolleg POKAL